Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antibody drugs
Pharma
J&J's Imaavy wins FDA green light in myasthenia gravis
The FDA on Wednesday approved J&J’s nipocalimab under the brand name Imaavy as a new treatment for generalized myasthenia gravis.
Fraiser Kansteiner
Apr 30, 2025 10:51am
Kyowa Kirin wraps up build out of $118M biologics plant
Apr 11, 2025 10:00am
Antibody expert Bio X Cell debuts Beijing distribution center
Feb 11, 2025 9:42am
Novo at last scores US green light for daily hemophilia med
Dec 23, 2024 10:33am
Sanofi blueprints €40M manufacturing upgrade in France
Nov 18, 2024 1:53pm
Novartis tasks Lindy to turn biologics into at-home injectables
Aug 28, 2024 10:18am
.jpg?VersionId=lqZY4CDGUvkKYC1pRIqZC.ztWXOzQzvk)
